113 related articles for article (PubMed ID: 18724288)
1. Allogeneic hematopoietic stem cell transplantation in Tunisia.
Ben Othman T; Torjemane L; Abdelkefi A; Lakhal A; Ladeb S; Ben Hamed L; Slama H; Ben Abdeladhim A
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S139-S141. PubMed ID: 18724288
[TBL] [Abstract][Full Text] [Related]
2. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic stem cell transplantation.
Bosi A; Bartolozzi B; Guidi S
Transplant Proc; 2005; 37(6):2667-9. PubMed ID: 16182779
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation in Lebanon: first comprehensive report.
Bazarbachi A; Hatoum H; Mugharbel A; Otrock Z; Yassine N; Muwakkit S; Salem Z; Shebbo W; Jisr T; Abboud M; Ibrahim A
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S96-S102. PubMed ID: 18724316
[TBL] [Abstract][Full Text] [Related]
6. The activity of hematopoietic stem cell transplantation in Korea.
Lee JW; Kim CC
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S92-S95. PubMed ID: 18724315
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
[TBL] [Abstract][Full Text] [Related]
8. European survey on clinical use of cord blood for hematopoietic and non-hematopoietic indications.
Gratwohl A; Baldomero H
Transfus Apher Sci; 2010 Jun; 42(3):265-75. PubMed ID: 20427240
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation in Oman.
Dennison D; Al Kindi S; Pathare A; Daar S; Nusrat N; Ur Rehman J; Zia F; Khan H; Khan MI; Alghazaly A; Al Zadjali S; Tauro M; Al Lawatia A; Ganguly S
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S109-S113. PubMed ID: 18724280
[TBL] [Abstract][Full Text] [Related]
10. EBMT activity survey 2004 and changes in disease indication over the past 15 years.
Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; ;
Bone Marrow Transplant; 2006 Jun; 37(12):1069-85. PubMed ID: 16757972
[TBL] [Abstract][Full Text] [Related]
11. Current status of hematopoietic stem cell transplantations in Vietnam.
van Be T; van Binh T; Binh N; Tuan T; Nghia H; Hien B
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S146-S148. PubMed ID: 18724291
[TBL] [Abstract][Full Text] [Related]
12. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases.
Cid J; Lozano M; Fernández-Avilés F; Carreras E; Pereira A; Mazzara R; Ordinas A
Transfusion; 2006 Feb; 46(2):169-73. PubMed ID: 16441590
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
[TBL] [Abstract][Full Text] [Related]
14. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
Gratwohl A; Baldomero H; Schwendener A; Rocha V; Apperley J; Frauendorfer K; Niederwieser D; ;
Bone Marrow Transplant; 2009 Feb; 43(4):275-91. PubMed ID: 19169283
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004.
Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Ma DD; Moore JJ; Simpson JM; Szer J
Biol Blood Marrow Transplant; 2007 Aug; 13(8):905-12. PubMed ID: 17640594
[TBL] [Abstract][Full Text] [Related]
16. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.
Al-Ali H; Cross M; Lange T; Freund M; Dölken G; Niederwieser D
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407
[TBL] [Abstract][Full Text] [Related]
17. Current status of hematopoietic stem cell transplantation in Taiwan.
Chen PM; Hsiao LT; Chen MH; Chang PM; Liu CY; Hong YC; Tzeng CH; Chiou TJ
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S133-S136. PubMed ID: 18724286
[TBL] [Abstract][Full Text] [Related]
18. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors.
Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; Niederwieser D; ;
Bone Marrow Transplant; 2007 Jan; 39(2):71-87. PubMed ID: 17213849
[TBL] [Abstract][Full Text] [Related]
19. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
[TBL] [Abstract][Full Text] [Related]
20. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
